ABLAZE PHARMACEUTICALS
Ablaze Pharma is a clinical stage bio-pharmaceutical company that is focused on developing Targeted Radiotherapy (TRT) to benefit cancer patients.
ABLAZE PHARMACEUTICALS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2011-04-01
Address:
Jingan, Shanghai, China
Country:
China
Website Url:
http://www.ablazepharma.com
Status:
Active
Total Funding:
75 M USD
Technology used in webpage:
Microsoft Exchange Online Office 365 Mail
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Nan Fung Life Sciences
Nan Fung Life Sciences investment in Series A - Ablaze Pharmaceuticals
Vivo Capital
Vivo Capital investment in Series A - Ablaze Pharmaceuticals
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series A - Ablaze Pharmaceuticals
Pivotal bioVenture Partners China
Pivotal bioVenture Partners China investment in Series A - Ablaze Pharmaceuticals
Samsara BioCapital
Samsara BioCapital investment in Series A - Ablaze Pharmaceuticals
Advantech Capital
Advantech Capital investment in Series A - Ablaze Pharmaceuticals
venBio Partners
venBio Partners investment in Series A - Ablaze Pharmaceuticals
RAYZ Investments
RAYZ Investments investment in Series A - Ablaze Pharmaceuticals
Official Site Inspections
http://www.ablazepharma.com Semrush global rank: 5.95 M Semrush visits lastest month: 1.38 K
- Host name: 13.91.228.57
- IP address: 13.91.228.57
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Ablaze Pharmaceuticals"
Ablaze Pharmaceuticals - Crunchbase Company Profile …
View contacts for Ablaze Pharmaceuticals to access new leads and connect with decision-makers.Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.See details»
Ablaze Pharmaceuticals - VentureRadar
DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and production in Denmark and …See details»
Ablaze Pharmaceuticals - LinkedIn
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company with a mission to bring advanced targeted radiopharmaceutical therapies (TRT) to benefit cancer patients in China. Since its ...See details»
Ablaze Pharmaceuticals - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Ablaze Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Ablaze Pharmaceuticals: Contact Details and Business Profile
Leveraging its team’s extensive business experience and network in cross-border product development and deal making, Ablaze strives to become the leader and the partner of choice …See details»
Ablaze Pharmaceuticals - CB Insights
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company with a mission to bring advanced targeted radiopharmaceutical therapies (TRT) to benefit cancer patients in China. …See details»
Ablaze Pharmaceuticals Launches with $75m Series A Financing to …
Nov 29, 2021 For more information, please visit www.ablazepharma.com About Vivo Capital Founded in 1996, Vivo Capital is a global investment firm focused on healthcare.See details»
Ablaze Pharmaceuticals - Craft
Ablaze Pharmaceuticals $75 m in total funding,. See insights on Ablaze Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Ablaze Pharmaceuticals - Portfolio Company Profile, Executives …
See Ablaze Pharmaceuticals's complete profile, including its private equity owner and the number of its executive contacts in our database. Ablaze Pharmaceuticals is a clinical stage …See details»
Ablaze Pharmaceuticals - Drug pipelines, Patents, Clinical trials
Explore Ablaze Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, 7 news.See details»
Ablaze Pharmaceuticals - ZoomInfo
Dec 25, 2022 View Ablaze Pharmaceuticals (www.ablazepharma.com) location in Shanghai, China , revenue, industry and description. Find related and similar companies as well as …See details»
Ablaze Pharmaceuticals Management Team | Org Chart
Co-Founder and Chief Operating Officer at Ablaze Pharmaceuticals Shanghai, China View 3 gmail.com ambrx.com ablazepharma.comSee details»
Ablaze Pharmaceuticals Launches with $75m Series A Financing to …
Nov 29, 2021 SHANGHAI and SAN DIEGO, Nov. 29, 2021 /PRNewswire/ -- Ablaze Pharmaceuticals ("Ablaze"), a clinical-stage pharmaceutical company focused on the …See details»
Ablaze Pharmaceuticals - VentureRadar
Founded in 2021, Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company with a mission to bring advanced targeted radiopharmaceutical therapies (TRT) to benefit cancer …See details»
Ablaze Pharmaceuticals and Yonghe Pharma Initiate Development …
Dec 28, 2022 Leveraging its team's extensive business experience and network in cross-border product development and deal making, Ablaze strives to become the leader and the partner of …See details»
Ablaze Pharma Launches with $75 Million to Bring Targeted ...
Dec 1, 2021 Shanghai-based Ablaze Pharmaceuticals has launched with a $75 million Series A round to develop targeted radiopharmaceutical therapies (TRT) against cancer in China. The …See details»
Ablaze Pharmaceuticals and Yonghe Pharma Initiate Development …
Dec 26, 2022 /PRNewswire/ -- Ablaze Pharmaceuticals ("Ablaze") announced the initiation of a development and manufacturing services agreement with Yonghe Pharmaceutical...See details»
Ablaze Pharmaceuticals Plans Development of Innovative GPC3 …
Mar 31, 2023 Leveraging its team's extensive business experience and network in cross-border product development and deal making, Ablaze strives to become the leader and the partner of …See details»
Ablaze Pharmaceuticals Plans Development of Innovative GPC3 …
SHANGHAI, March 31, 2023 /PRNewswire/ -- Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted Radiotherapy (TRT) to benefit cancer patients in China, today …See details»
Ablaze Pharmaceuticals Plans Development of Innovative GPC3 …
Mar 31, 2023 /PRNewswire/ -- Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted Radiotherapy (TRT) to benefit cancer patients in China, today...See details»